Effects of anti-anaphylactic drugs upon passive cutaneous anaphylaxis mediated by graded doses of reaginic or non-reaginic antibodies in rats.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000418:Albumins / Q000276:immunology; D000420:Albuterol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D002744:Chlorpheniramine / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology*; D005029:Ethylenediamines / Q000494:pharmacology; D007073:Immunoglobulin E; D007545:Isoproterenol / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology*; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects*; D011725:Pyridines / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D011935:Reagins; D013876:Thiophenes / Q000494:pharmacology; D014105:Tosyl Compounds / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D000418:Albumins; D000605:Amino Alcohols; D005029:Ethylenediamines; D011725:Pyridines; D011935:Reagins; D013876:Thiophenes; D014105:Tosyl Compounds; D000628:Aminophylline; D007073:Immunoglobulin E; D002744:Chlorpheniramine; D007545:Isoproterenol; D004205:Cromolyn Sodium; D000420:Albuterol; D008784:Methysergide